Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B-Cell Lymphoma Full Text
The Oncologist, 06/22/2012
Spina M et al. – Chemoimmunotherapy adjustments based on a comprehensive geriatric assessment (CGA) are associated with manageable toxicity and excellent outcomes in elderly patients with diffuse large B–cell lymphoma (DLBCL). Wide use of this CGA–driven treatment may result in better cure rates, especially in fit and unfit patients.